CAMBRIDGE, Mass.--(BUSINESS WIRE)--Concerto Biosciences, a biotechnology company designing microbial communities that restore deficient microbiomes to treat disease, announced today that it raised $23 ...
Bristol-Myers Squibb’s research efforts will be getting an artificial intelligence boost thanks to a new multi-year deal signed by the pharmaceutical company and Concerto HealthAI, the maker of a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results